Authors/Disclosures
|
Jeremy M. Shefner, MD, PhD, FÂ鶹´«Ã½Ó³»
(Barrow Neurological Institute)
|
Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Uniqure. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Shefner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cytokinetics. Dr. Shefner has received personal compensation in the range of $0-$499 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for annexon. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurosense. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuvivo. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nura BIo. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for swanbio. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vertex. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Shefner has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Shefner has received research support from NIH. The institution of Dr. Shefner has received research support from Mitsubishi Tanabe Pharma America. The institution of Dr. Shefner has received research support from Amylyx. The institution of Dr. Shefner has received research support from BIogen. The institution of Dr. Shefner has received research support from Cytokinetics. The institution of Dr. Shefner has received research support from IONIS. The institution of Dr. Shefner has received research support from Healey Center for ALS. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a grant review chair with DOD- General Dynamics. |
|
Jinsy Andrews, MD, FÂ鶹´«Ã½Ó³»
(NYU Langone Health)
|
Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Cytokinetics. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Regeneron. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Bristol Meyer Squibb. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AL-S Pharma. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quralis . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neurosense. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Akava. The institution of Dr. Andrews has received research support from Amylyx. The institution of Dr. Andrews has received research support from Biogen . The institution of Dr. Andrews has received research support from Cytokinetics . The institution of Dr. Andrews has received research support from NIH . The institution of Dr. Andrews has received research support from Prilenia/Platform Trial . The institution of Dr. Andrews has received research support from ALS Platform Trial . The institution of Dr. Andrews has received research support from Corcept. |
|
Richard S. Bedlack, MD, PhD, FÂ鶹´«Ã½Ó³»
|
Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AB Science. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ALS Hope Foundation. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amylyx. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Capvision. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Carespace. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clene Nanomedicine. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Compassionate Care ALS. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eikonoclastes. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Haim Pharma. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Care Strategy Partners. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for i3 Health. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Impossible Dream Machine. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InThought. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kaplan. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeyQuest. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Launch Bio. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH HealthCare. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Med-IQ. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicinova. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurosense. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharma. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prime Â鶹´«Ã½Ó³». Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roon. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurosense. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for GenieUS Genomics. The institution of Dr. Bedlack has received research support from MediciNova. The institution of Dr. Bedlack has received research support from Healey Center. Dr. Bedlack has received publishing royalties from a publication relating to health care. |
|
James D. Berry, MD MPH
(Massachusetts General Hospital)
|
Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene Nanomedicine. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma Holdings of America. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berry has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Berry has stock in ReactNeuro. The institution of Dr. Berry has received research support from Biogen. The institution of Dr. Berry has received research support from MT Pharma of America. The institution of Dr. Berry has received research support from Rapa Therapeutics. The institution of Dr. Berry has received research support from Brainstorm Cell Therapeutics. The institution of Dr. Berry has received research support from Alexion. The institution of Dr. Berry has received research support from nQ Medical. The institution of Dr. Berry has received research support from ALSA. The institution of Dr. Berry has received research support from MDA. The institution of Dr. Berry has received research support from Amylyx. The institution of Dr. Berry has received research support from Transposon. Dr. Berry has a non-compensated relationship as a Scientific Advisor with Everything ALS that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
|
Kimberly L. Goslin, MD
(Providence Medical Center)
|
No disclosure on file |
|
Carlayne E. Jackson, MD, FÂ鶹´«Ã½Ó³»
(University of Texas Health Science Center at San Antonio)
|
Dr. Jackson has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Â鶹´«Ã½Ó³». The institution of Dr. Jackson has received research support from NIH. The institution of Dr. Jackson has received research support from Massachussetts General Hospital. |
|
|
No disclosure on file |
|
John T. Kissel, MD, FÂ鶹´«Ã½Ó³»
|
Dr. Kissel has nothing to disclose. |
|
Dale J. Lange, MD, FÂ鶹´«Ã½Ó³»
(Lange Neurology, PC)
|
No disclosure on file |
|
Jonathan M. Licht, MD
|
No disclosure on file |
|
Tahseen Mozaffar, MD, FÂ鶹´«Ã½Ó³»
(University of California Irvine)
|
Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annji. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CARTESIAN. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. The institution of Dr. Mozaffar has received research support from Aro Bio. The institution of Dr. Mozaffar has received research support from Shionogi. The institution of Dr. Mozaffar has received research support from Ask Bio. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. |
|
Alan Pestronk, MD, FÂ鶹´«Ã½Ó³»
(Washington University in Saint Louis - Neurology)
|
The institution of Dr. Pestronk has received research support from Jain. The institution of Dr. Pestronk has received research support from Fulcrum. The institution of Dr. Pestronk has received research support from Argenyx. The institution of Dr. Pestronk has received research support from NeuroNext. |
|
Jeffrey Rosenfeld, MD, PhD, FÂ鶹´«Ã½Ó³»
(Loma Linda University School Medicine - NEUROLOGY)
|
Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ML Biosolutions. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for MT Pharma America. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroSense. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexion. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurizon. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serano/EMD. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anelixis. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AcuraStem. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroSense. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for MT Pharma America. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Strongbridge Pharma. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Rosenfeld has received research support from MT Pharma. The institution of Dr. Rosenfeld has received research support from Alexion. The institution of Dr. Rosenfeld has received research support from Healey ALS Trial Center Mass General. |
|
Andrew A. Wolff, MD
(Cytokinetics, Inc.)
|
No disclosure on file |
|
Jacqueline Lee
|
No disclosure on file |
|
|
No disclosure on file |
|
Drew S. Jones, MD, MPH
(Baxter Health Care Corp)
|
No disclosure on file |
|
Lisa Meng
(Cytokinetics)
|
No disclosure on file |
|
Jesse M. Cedarbaum, MD, FÂ鶹´«Ã½Ó³»
(Coeruleus Clinical Sciences LLC)
|
No disclosure on file |